C. Davidson

发表

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

H. Putter, C. Haie-meder, H. Kitchener, 2018, The Lancet. Oncology.

FAK promotes stromal PD-L2 expression associated with poor survival in pancreatic cancer

A. Sims, A. Serrels, M. Canel, 2020, British Journal of Cancer.

Feline injection site sarcoma: current paradigms and future directions

J. Lawrence, C. Davidson, 2016 .

FAK-regulated IL6 reprograms the tumour associated macrophage phenotype and promotes pancreatic tumour growth

C. Davidson, 2019 .

Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology.

I. Mills, D. Neal, H. Pandha, 2017, European urology.

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

H. Putter, C. Haie-meder, H. Kitchener, 2019, The Lancet. Oncology.

FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer.

A. Biankin, A. von Kriegsheim, A. Serrels, 2022, Gut.

Canine phaeochromocytoma: diagnosis and surgical management

C. Davidson, 2022, Companion Animal.

FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer

A. Biankin, A. von Kriegsheim, A. Serrels, 2023, Gut.